The Journal of Neuroscience, December 19, 2007, 27(51):14117-14127; doi:10.1523/JNEUROSCI.3884-07.2007
Previous Article | Next Article 
Cellular/Molecular
Expression and Localization of RGS9-2/Gβ5/R7BP Complex In Vivo Is Set by Dynamic Control of Its Constitutive Degradation by Cellular Cysteine Proteases
Garret R. Anderson,1
Rafael Lujan,2
Arthur Semenov,1
Marco Pravetoni,1
Ekaterina N. Posokhova,1
Joseph H. Song,1
Vladimir Uversky,3,4
Ching-Kang Chen,5
Kevin Wickman,1 and
Kirill A. Martemyanov1
1Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, 2Departamento de Ciencias Médicas, Facultad de Medicina, Universidad de Castilla-La Mancha, 02006 Albacete, Spain, 3Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana 46202, 4Institute for Biological Instrumentation, Russian Academy of Sciences, Pushchino, 142290, Russia, and 5Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia 23298
Correspondence should be addressed to Dr. Kirill Martemyanov, Department of Pharmacology, 6-120 Jackson Hall, 321 Church Street SE, Minneapolis, MN 55455. Email: martemyanov{at}umn.edu
A member of regulator of G-protein signaling family, RGS9-2, is an essential modulator of signaling through neuronal dopamine and opioid G-protein-coupled receptors. Recent findings indicate that the abundance of RGS9-2 determines sensitivity of signaling in the locomotor and reward systems in the striatum. In this study we report the mechanism that sets the concentration of RGS9-2 in vivo, thus controlling G-protein signaling sensitivity in the region. We found that RGS9-2 possesses specific degradation determinants which target it for constitutive destruction by lysosomal cysteine proteases. Shielding of these determinants by the binding partner R7 binding-protein (R7BP) controls RGS9-2 expression at the posttranslational level. In addition, binding to R7BP in neurons targets RGS9-2 to the specific intracellular compartment, the postsynaptic density. Implementation of this mechanism throughout ontogenetic development ensures expression of RGS9-2/type 5 G-protein β subunit/R7BP complexes at postsynaptic sites in unison with increased signaling demands at mature synapses.
Key words: G-protein; signal transduction; RGS proteins; protein degradation; intracellular targeting; striatum
Received Aug. 24, 2007;
revised Oct. 15, 2007;
accepted Nov. 6, 2007.
Correspondence should be addressed to Dr. Kirill Martemyanov, Department of Pharmacology, 6-120 Jackson Hall, 321 Church Street SE, Minneapolis, MN 55455. Email: martemyanov{at}umn.edu
This article has been cited by other articles:

|
 |

|
 |
 
G. R. Anderson, R. Lujan, and K. A. Martemyanov
Changes in Striatal Signaling Induce Remodeling of RGS Complexes Containing G{beta}5 and R7BP Subunits
Mol. Cell. Biol.,
June 1, 2009;
29(11):
3033 - 3044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Martemyanov, C. M. Krispel, P. V. Lishko, M. E. Burns, and V. Y. Arshavsky
Functional comparison of RGS9 splice isoforms in a living cell
PNAS,
December 30, 2008;
105(52):
20988 - 20993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Cao, H. Song, H. Okawa, A. P. Sampath, M. Sokolov, and K. A. Martemyanov
Targeting of RGS7/G{beta}5 to the Dendritic Tips of ON-Bipolar Cells Is Independent of Its Association with Membrane Anchor R7BP
J. Neurosci.,
October 8, 2008;
28(41):
10443 - 10449.
[Abstract]
[Full Text]
[PDF]
|
 |
|